Vahearuanne Telescan AS vahearuanne seisuga 30. juuni

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Vahearuanne

Telescan AS vahearuanne seisuga 30. juuni 2014

2013. aasta teises ja 2014. esimeses pooles viis Telecan ellu oma strateegilise äriplaani esimese etapi. Telescani ennetava meditsiini skaneerimise tehnoloogiatel põhinev unikaalne strateegiline kava toetab tõhusalt profülaktilise tervishoiu arengut, võimaldades inimestel elada tervemalt ja kauem. Protsessi esimeses sammus analüüsime DNA biomarkerite tuntud riske - eelsoodumust ühe või mitme eluohtliku haiguse tekkeks aja jooksul. Teises etapis toimub kord või kaks aastas MRT skaneering kontrollimaks organismi tervislikku seisundit. Kui skaneerimise käigus leitakse märke algusfaasis olevatest haigustest, võimaldab varajane sekkumine saavutada palju paremaid ravitulemusi võrreldes meditsiinilise seisundiga, mil avalduvad juba kliinilised sümptomid. Telescani profülaktiline lähenemine võimaldab haiguse varajast tuvastamist ning suurendab  ravi õnnestumise tõenäosust.

Telescani kahetasandiline profülaktilise skaneerimise strateegia pakub tulutootluseks mitmekülgseid võimalusi.

Ennetava meditsiini ärimudeli edukaks turundamiseks rakendab Telescan  frantsiisiformaatiformaati, mille globaalseks väljaarendamiseks hetkel ettevalmistusi tehakse. Praeguseks on allkirjastamisel kolm frantsiisilepet, mis 6 kuu jooksul alates 1. juulist 2014 peaksid hakkama tulu tootma. Hetkel toimuvad läbirääkimised edasisteks frantsiisi turundusvõimalusteks. Eelseisva kuue kuu jooksul alustab ettevõte ka aktiivset turunduskampaaniat.

Suur osa käesolevas finantsaruandes toodud kuludest on juriidilised, majandusarvestuse ja nõustamise eest makstavad tasud, mis on seotud ettevõtte ärimudeli arendamisega.

Suurem hulk Telescani aktsiad on juba müüdud kasvava ülekursiga üle nominaalväärtuse. Plaanide kohaselt õnnestub kogu esialgne lubatud aktsiakapital 100 000 eurot täielikult ära märkida 2014 aasta lõpuks. Seejärel kavatseb ettevõte jätkata oma kapitalibaasi ehitamist uute lisainvesteeringute kaasamisega.

 Bilanss

         
eurodes 30.06.2014 31.12.2013    
         
Varad        
         
Käibevarad        
Raha 1 013 2 357    
Nõuded ja ettemaksed 8 019 6 374    
Käibevarad kokku 9 032 8 731    
         
Põhivarad        
Materiaalne põhivara 19 974 23 047    
Põhivara kokku 19 974 23 047    
         
Varad kokku 29 006 31 778    
         
Kohustused ja omakapital        
         
Omakapital        
Aktsiakapital 75 500 60 000    
Registreerimata aktsiakapital 23 000 0    
Ülekurss 35 500 10 000    
Eelmiste perioodide jaotamata kasum/- kahjum -69 930 0    
Perioodi kasum -62 564 -69 930    
Omakapital kokku 1 506 70    
         
Lühiajalised kohustused        
Võlad ja ettemaksed 27 500 31 708    
Lühiajalised kohustused kokku 27 500 31 708    
Kohustused kokku 27 500 31 708    
         
Omakapital ja kohustused kokku 29 006 31 778    
                 

Kasumiaruanne

       
eurodes 01.01-30.06.2014 30.05-30.06.2013    
         
Müügitulu 2 250 0    
Muud äritulud 1 0    
Mitmesugused tegevuskulud -56 436 -179    
Tööjõu kulud -5 301 0    
Põhivara kulum ja väärtuse langus -3 073 0    
Muud ärikulud -5 0    
Ärikasum -62 564 -179    
Kasum enne tulumaksukulu -62 564 -179    
Puhaskasum -62 564 -179    
               

Rahavoogude aruanne

       
eurodes 01.01- 30.06.2014 30.05-30.06.2013    
Rahavood äritegevusest        
Ärikasum -62 564 -179    
Põhivara kulum ja väärtuse langus 3 073 0    
Äritegevusega seotud nõuete ja ettemaksete muutus -1 645 0    
Äritegevusega seotud kohustuste ja ettemaksete muutus -4 208 179    
Kokku rahavood äritegevusest -65 344 0    
         
Rahavood investeerimistegevusest        
Tasutud materiaalse põhivara soetamisel 0 0    
Kokku rahavood investeerimistegevusest 0 0    
         
Rahavood finantseerimistegevusest        
Saadud laenud 0      
Saadud laenude tagasimaksed 0 0    
Laekunud aktsiate või osade emiteerimisest 64 000 25 000    
Kokku rahavood finantseerimistegevusest 64 000 25 000    
         
Rahavood kokku -1 344 25 000    
         
Raha ja raha ekvivalentide muutus -1 344 25 000    
Raha ja raha ekvivalendid perioodi alguses 2 357 0    
Raha ja raha ekvivalendid perioodi lõpus 1 013 25 000    
               

 Omakapitali muutuste aruanne

         
eurodes          
  Aktsiakapital Registreerimata aktsiakapital Ülekurss Jaotamata kasum/- kahjum Kokku
Saldo 30.05.2013 25 000 0 0 0 25 000
Aruandeperioodi kasum 0 0 0 -179 -179
Saldo 30.06.2013 25 000 0 0 -179 24 821
Emiteeritud aktsiakapital 35 000 0 10 000 0 45 000
Aruandeperioodi kasum 0 0 0 -69 751 -69 751
Saldo 31.12.2013 60 000 0 10 000 -69 930 70
Emiteeritud aktsiakapital 15 500 23 000 25 500 0 64 000
Aruandeperioodi kasum 0 0 0 -62 564 -62 564
Saldo 30.06.2014 75 500 23 000 35 500 -132 494 1 506

         Michael Chambers          COO          Telescan AS          +44 79 6404 8080          mc@telescan.ee

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 595

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 21

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 193

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Buena Vida y Salud ACO Celebrated for Value-Based Care Innovation

Updated Category News Views 120

Buena Vida y Salud ACO Achieves National Recognition Buena Vida y Salud ACO has garnered significant acclaim as a recipient of the prestigious 2024 NAACOS Excellence Awards. This recognition highlights the organization's successful dedication to value-based care, shaping effective healthcare solutions tailored for patient needs. Leadership and Commitment to...

Continue Reading
SSCP Lager Bidco AB Shares Insights in Quarterly Report

Updated Category News Views 162

SSCP Lager Bidco AB Shares Insights in Quarterly Report Introduction to the Interim Report SSCP Lager Bidco AB (publ) recently released an interim report detailing the developments from April 1 to June 30 of a specific year, highlighting significant milestones and financial performance. Key Highlights of the Interim Report In this latest report, SSCP Lager Bidco AB...

Continue Reading
Important Corrections to ForFarmers N.V. Shareholder Meeting

Updated Category News Views 167

Update on the Resolutions of ForFarmers N.V. Annual General Meeting In a recent communication regarding the resolutions from the Annual General Meeting of Shareholders at ForFarmers N.V., some critical information was initially misstated. This announcement focuses on clarifying these details to ensure transparency and keep our stakeholders well-informed. Corrections to...

Continue Reading
Strong Increase in U.S. House Prices Despite Rising Rates

Updated Category News Views 90

U.S. House Prices Show Remarkable Growth The latest data reveals that U.S. single-family house prices experienced a strong increase in September, presenting challenges for many potential homeowners due to rising costs. This upward trend in the housing market is noteworthy, particularly as mortgage rates have begun to climb. Monthly Price Adjustments According to the...

Continue Reading
Upbeat BidCo Increases Buyout Offer Price for Believe's Shares

Updated Category News Views 208

Upbeat BidCo Raises Its Public Buyout Offer for Believe In an exciting development for investors, Upbeat BidCo has decided to increase its public buyout offer for Believe to 17.20 euros per share. This decision reflects a commitment to maximizing shareholder value while ensuring the future growth of Believe, a prominent digital music company. Significant Premium on the...

Continue Reading